You can schedule an appointment at your local pharmacy, such as CVS, Walgreens, Safeway, or your primary care physician to get the RSV vaccine. The CDC said it is safe to get your RSV, flu and COVID ...

The potential of mRNA vaccines was established during the COVID-19 pandemic. Now, a new wave of candidates could soon hit the ...

Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...

AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. | The FDA signed off on ...

Moderna shares have dropped by over -41.67% since I last covered them over the summer. See why I continue to rate MRNA stock ...

It is not inevitable that H5N1 will develop into a pandemic -- if we act now. Unfortunately, instead of urgent action, we ...

PHN is characterised by pain lasting from three months to several years after the rash subsides, and it is also the most ...

Moderna jolted investors by pushing back its profitability forecast two years, to 2028, and announcing a $1.1 billion cut in R&D spending.

The new agreement comes at a time when GSK and CureVac have been at risk of falling behind in mRNA vaccines for respiratory diseases, with combined flu/COVID-19 candidates from Moderna and Pfizer ...

Moderna stock tumbled again Friday on a series of downgrades and price-target cuts following a "tough update" at its R&D Day.

GlaxoSmithKline has agreed to supply its vaccine adjuvant technology to Clover Biopharma, to help the Chinese biotech in its efforts to develop a vaccine against new coronavirus COVID-19.